Supplements
Supplement: Current and Emerging Treatment Approaches Addess Unmet Needs in Glaucoma Care
Sustained-release implants and micro- or minimally invasive glaucoma surgeries (MIGS) are emerging therapies that address key unmet needs in glaucoma treatment. By broadening the spectrum of interventions, these therapies allow glaucoma specialists to consider more measured approaches earlier in disease progression, with a view to delay as well as safeguard the possibility of further invasive surgeries. Drs. Herbert Reitsamer, Andrew Tatham, and Iqbal Ike K. Ahmed discuss how patient compliance impacts glaucoma progression, the role of sustained-release drug delivery and MIGS in alleviating patient treatment burden, the use of MIGS in combination with cataract surgery, and how these therapies can be incorporated into the treatment paradigm.
Tags: glaucoma
Latest Articles
Going Beyond Cataract Camps
ESCRS expanding treatment opportunities in underserved areas.
Bridging the Gap Between Local and Global
New training programmes seek to reach hard-to-reach areas to meet growing patient needs.
2024 Congress Draws Global Audience, Strengthens Ties
Refractive EDOF with the Benefits of Monofocal
PureSee IOL studies indicate high patient satisfaction.
Making the Right IOL Decisions
Use of presbyopia-correcting lenses in post-corneal refractive surgery patients requires attention to multiple considerations.
Training to Target Global Cataract Blindness
Non-profit organisations look to innovative, scalable virtual reality training systems.
ESCRS Refractive Surgery Guidelines a Work in Progress
Challenges involve keeping up to date on current treatments.
Stabilising with PACE-CXL
Performed with advanced technologies, PACE-CXL procedure stops ectatic progression and improves vision.
Closing the Mentorship Distance
Addressing a need in underserved regions, distance surgical mentorship offers a viable strategy with multiple benefits.